Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.

Clinical imaging - 1 Jan 2000

Grubstein Ahuva, Rapson Yael, Benzaquen Oshra, Rozenblatt Shira, Gadiel Itay, Atar Eli, Yerushalmi Rinat, Cohen Matan J

Abstract excerpt

OBJECTIVE: High background parenchymal enhancement and amount of fibroglandular tissue on breast magnetic resonance imaging are related to increased breast cancer risk. This study sought to compare these parameters between BRCA mutation carriers and non-carriers and to evaluate the potential implications of the findings for short term follow-up. MATERIALS AND METHODS: Magnetic resonance imaging studies of known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Genes, BRCA1

Share to Heterozygote

Share to Magnetic Resonance Imaging

Share to Mutation

Source

Identifiers

PMID: 29982132
DOI: 10.1016/j.clinimag.2018.06.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.PMID 29982132Read ↗

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.Semantic proximity Read ↗

Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Assessment of Background Parenchymal Enhancement and Lesion Kinetics in Breast MRI of BRCA 1/2 Mutation Carriers Compared to Matched Controls Using Quantitative Kinetic Analysis.Semantic proximity Read ↗

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women.Semantic proximity Read ↗

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis.Semantic proximity Read ↗

Qualitative Assessments of Density and Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography Associated with Breast Cancer Risk of High-Risk WomenSemantic proximity Read ↗

MRI phenotypes associated with breast cancer predisposing genetic variants, a multisite review.Semantic proximity Read ↗

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.Semantic proximity Read ↗

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?Semantic proximity Read ↗

Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.Semantic proximity Read ↗

Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.Semantic proximity Read ↗

Screening in Women With BRCA Mutations Revisited.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.